KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Encompass Health (EHC) over the last 13 years, with Q3 2025 value amounting to $45.0 million.

  • Encompass Health's Short-term Investments fell 1193.74% to $45.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year decrease of 1193.74%. This contributed to the annual value of $37.7 million for FY2024, which is 740.74% up from last year.
  • According to the latest figures from Q3 2025, Encompass Health's Short-term Investments is $45.0 million, which was down 1193.74% from $38.3 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Short-term Investments registered a high of $73.6 million during Q3 2021, and its lowest value of $27.0 million during Q1 2025.
  • In the last 5 years, Encompass Health's Short-term Investments had a median value of $41.5 million in 2023 and averaged $46.1 million.
  • In the last 5 years, Encompass Health's Short-term Investments tumbled by 4944.0% in 2022 and then surged by 3826.71% in 2025.
  • Quarter analysis of 5 years shows Encompass Health's Short-term Investments stood at $62.5 million in 2021, then tumbled by 49.44% to $31.6 million in 2022, then increased by 11.08% to $35.1 million in 2023, then rose by 7.41% to $37.7 million in 2024, then rose by 19.36% to $45.0 million in 2025.
  • Its last three reported values are $45.0 million in Q3 2025, $38.3 million for Q2 2025, and $27.0 million during Q1 2025.